{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:39:56Z","timestamp":1787027996308,"version":"build-2736575974"},"reference-count":25,"publisher":"American Diabetes Association","issue":"10","license":[{"start":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T00:00:00Z","timestamp":1630108800000},"content-version":"vor","delay-in-days":4434,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,10,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>Diabetic large\u2013nerve fiber dysfunction, as measured by vibration perception threshold (VPT), predicts foot ulceration, amputation, and mortality. Thus, determination of modifiable risk factors is of great clinical importance.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                  <jats:p>We assessed 1,407 patients with type 1 diabetes and a normal VPT participating in the EURODIAB Prospective Complications Study, at baseline mean \u00b1 SD age of 32.7 \u00b1 10.2 years with diabetes duration of 14.7 \u00b1 9.3 years and follow-up of 7.3 \u00b1 0.6 years. VPT was measured using biothesiometry on the right big toe and medial malleolus. An abnormal result was defined as &amp;gt;2 SD from the predicted mean for the patient s age.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>An abnormal VPT was associated with an increased incidence of gangrene, amputation, foot ulceration, leg bypass or angioplasty, and mortality (P \u2264 0.02). The incidence of abnormal VPT was 24% over the 7.3-year follow-up. Duration of diabetes and A1C significantly influenced the incidence of abnormal VPT (P &amp;lt; 0.0001). After correction for these, established risk factors for cardiovascular disease (CVD), including male sex (P = 0.0004), hypertension (P &amp;lt; 0.0001), total cholesterol (P = 0.002), LDL cholesterol (P = 0.01), smoking (P &amp;lt; 0.0001), weight (P &amp;lt; 0.0001), and diabetes complications (retinopathy [P = 0.0001], nephropathy [P = 0.01], and autonomic neuropathy [P = 0.001]), were all found to be significant risk factors. A previous history of CVD doubled the incidence of abnormal VPT.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>This prospective study indicates that cardiovascular risk factors predict development of large-fiber dysfunction, which may account for the high mortality rate in patients with an abnormal VPT, and emphasizes the importance of early determination of VPT to detect subclinical neuropathy and to address cardiovascular risk factors.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/dc09-0554","type":"journal-article","created":{"date-parts":[[2009,7,9]],"date-time":"2009-07-09T02:28:42Z","timestamp":1247106522000},"page":"1896-1900","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":76,"title":["Large-Fiber Dysfunction in Diabetic Peripheral Neuropathy Is Predicted by Cardiovascular Risk Factors"],"prefix":"10.2337","volume":"32","author":[{"given":"Jackie","family":"Elliott","sequence":"first","affiliation":[{"name":"Diabetes Research Unit, Royal Hallamshire Hospital, Sheffield, U.K.;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solomon","family":"Tesfaye","sequence":"additional","affiliation":[{"name":"Diabetes Research Unit, Royal Hallamshire Hospital, Sheffield, U.K.;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nish","family":"Chaturvedi","sequence":"additional","affiliation":[{"name":"National Heart and Lung Institute, Imperial College at St. Mary's, London, U.K.;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv A.","family":"Gandhi","sequence":"additional","affiliation":[{"name":"Diabetes Research Unit, Royal Hallamshire Hospital, Sheffield, U.K.;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynda K.","family":"Stevens","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Public Health, Imperial College of Science, Technology and Medicine, London, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celia","family":"Emery","sequence":"additional","affiliation":[{"name":"Diabetes Research Unit, Royal Hallamshire Hospital, Sheffield, U.K.;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Fuller","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Public Health, Imperial College of Science, Technology and Medicine, London, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the EURODIAB Prospective Complications Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2009,7,8]]},"reference":[{"key":"2022031218145947100_B1","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.2337\/diacare.25.11.2010","article-title":"Can motor nerve conduction velocity predict foot problems in diabetic subjects over a 6-year outcome period?","volume":"25","author":"Carrington","year":"2002","journal-title":"Diabetes Care"},{"key":"2022031218145947100_B2","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.2337\/diacare.22.7.1029","article-title":"Lower-extremity amputation in diabetes: the independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers","volume":"22","author":"Adler","year":"1999","journal-title":"Diabetes Care"},{"key":"2022031218145947100_B3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/qjmed\/hcl140","article-title":"Predicting foot ulcers in patients with diabetes: a systematic review and meta-analysis","volume":"100","author":"Crawford","year":"2007","journal-title":"Q J Med"},{"key":"2022031218145947100_B4","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.2337\/diacare.26.6.1790","article-title":"The health care costs of peripheral neuropathy for people with diabetes in the U.S","volume":"26","author":"Gordois","year":"2003","journal-title":"Diabetes Care"},{"key":"2022031218145947100_B5","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.2337\/diacare.26.8.2305","article-title":"Predicted costs and outcomes from reduced vibration detection in people with diabetes in the U.S","volume":"26","author":"Shearer","year":"2003","journal-title":"Diabetes Care"},{"key":"2022031218145947100_B6","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2337\/diacare.24.2.250","article-title":"Simple screening tests for peripheral neuropathy in the diabetes clinic","volume":"24","author":"Perkins","year":"2001","journal-title":"Diabetes Care"},{"key":"2022031218145947100_B7","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.2337\/diacare.28.9.2201","article-title":"Back to basics in diagnosing with diabetic polyneuropathy with the tuning fork","volume":"28","author":"Meijer","year":"2005","journal-title":"Diabetes Care"},{"key":"2022031218145947100_B8","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.2337\/diacare.22.9.1479","article-title":"Risk factors for severity of diabetic polyneuropathy","volume":"22","author":"Dyck","journal-title":"Diabetes Care"},{"key":"2022031218145947100_B9","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.2337\/dc06-0525","article-title":"Modeling chronic glycemic exposure variables as correlates and predictors of microvascular complications of diabetes","volume":"29","author":"Dyck","year":"2006","journal-title":"Diabetes Care"},{"key":"2022031218145947100_B10","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0168-8227(02)00010-4","article-title":"Insensate versus painful diabetic neuropathy: the effects of height, gender, ethnicity and glycaemic control","volume":"57","author":"Sorensen","year":"2002","journal-title":"Diabetes Res Clin Pract"},{"key":"2022031218145947100_B11","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/(SICI)1096-9136(199809)15:9<765::AID-DIA663>3.0.CO;2-1","article-title":"Outcome on diabetic foot complications in relation to clinical examination and quantitative sensory testing: a case-control study","volume":"15","author":"Coppini","year":"1998","journal-title":"Diabet Med"},{"key":"2022031218145947100_B12","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2337\/diacare.17.6.557","article-title":"The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds: a prospective study","volume":"17","author":"Young","year":"1994","journal-title":"Diabetes Care"},{"key":"2022031218145947100_B13","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.2337\/diacare.21.7.1071","article-title":"Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration","volume":"21","author":"Abbott","year":"1998","journal-title":"Diabetes Care"},{"key":"2022031218145947100_B14","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.diabres.2005.02.013","article-title":"A comparison of the monofilament with other testing modalities for foot ulcer susceptibility","volume":"70","author":"Miranda-Palma","year":"2005","journal-title":"Diabetes Res Clin Prac"},{"key":"2022031218145947100_B15","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.2337\/diacare.27.6.1343","article-title":"Comparative roles of microvascular and nerve function in foot ulceration in type 2 diabetes","volume":"27","author":"Krishnan","year":"2004","journal-title":"Diabetes Care"},{"key":"2022031218145947100_B16","first-page":"847","article-title":"Sensory function at diagnosis and in early stages of NIDDM in patients detected through screening","volume":"16","author":"Sosenko","year":"1993","journal-title":"Diabetes Care"},{"key":"2022031218145947100_B17","doi-asserted-by":"crossref","first-page":"613","DOI":"10.2337\/diacare.10.5.613","article-title":"Influence of height on quantitative sensory, nerve-conduction and clinical indices of diabetic peripheral neuropathy","volume":"10","author":"Gadia","year":"1987","journal-title":"Diabetes Care"},{"key":"2022031218145947100_B18","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1136\/bmj.288.6433.1793","article-title":"Use of a biothesiometer to measure individual vibration thresholds and their variation in 519 non-diabetic subjects","volume":"288","author":"Bloom","year":"1984","journal-title":"Br Med J"},{"key":"2022031218145947100_B19","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1464-5491.1991.tb01563.x","article-title":"Vibration perception threshold: influence of age, height, sex, and smoking, and calculation of accurate centile values","volume":"8","author":"Wiles","year":"1991","journal-title":"Diabet Med"},{"key":"2022031218145947100_B20","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/BF00398055","article-title":"Microvascular and acute complications in IDDM patients","volume":"37","author":"The EURODIAB Prospective Complications Study Group.","year":"1994","journal-title":"Diabetologia"},{"key":"2022031218145947100_B21","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa032782","article-title":"Vascular risk factors and diabetic neuropathy","volume":"352","author":"Tesfaye","year":"2005","journal-title":"N Engl J Med"},{"key":"2022031218145947100_B22","doi-asserted-by":"crossref","first-page":"284","DOI":"10.2337\/diacare.24.2.284","article-title":"Markers of insulin resistance are strong risk factors for retinopathy incidence in type 1 diabetes","volume":"24","author":"Chaturvedi","year":"2001","journal-title":"Diabetes Care"},{"key":"2022031218145947100_B23","first-page":"A3","article-title":"Podiatry-led neuropathy ulcer clinics allow effective management of limited time and resources (Abstract)","volume":"45","author":"Elliott","year":"2002","journal-title":"Diabetologia"},{"key":"2022031218145947100_B24","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1445-5994.2005.00880.x","article-title":"Which patients should receive podiatry care? An objective analysis","volume":"35","author":"McGill","year":"2005","journal-title":"Intern Med J"},{"key":"2022031218145947100_B25","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.2337\/diacare.28.6.1383","article-title":"Diabetic retinopathy is associated with mortality and cardiovascular disease incidence: the EURODIAB Prospective Study","volume":"28","author":"Van Hecke","year":"2005","journal-title":"Diabetes Care"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/32\/10\/1896\/664843\/zdc01009001896.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/32\/10\/1896\/664843\/zdc01009001896.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T19:16:14Z","timestamp":1647112574000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/32\/10\/1896\/25946\/Large-Fiber-Dysfunction-in-Diabetic-Peripheral"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,8]]},"references-count":25,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2009,7,8]]},"published-print":{"date-parts":[[2009,10,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc09-0554","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,8]]}}}